Travere Therapeutics (TVTX) Net Cash Flow (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.41% |
| Dec 31, 2025 | -149.15% |
| Sep 30, 2025 | 214.55% |
| Jun 30, 2025 | 301.85% |
| Mar 31, 2025 | -90.79% |
| Dec 31, 2024 | 733.32% |
| Sep 30, 2024 | 133.46% |
| Jun 30, 2024 | 24.61% |
| Mar 31, 2024 | 94.97% |
| Dec 31, 2023 | -1,458.06% |
| Sep 30, 2023 | 129.44% |
| Jun 30, 2023 | -188.78% |
| Mar 31, 2023 | 172.43% |
| Dec 31, 2022 | -44.31% |
| Sep 30, 2022 | -3.61% |
| Jun 30, 2022 | -181.81% |
| Mar 31, 2022 | 320.38% |
| Dec 31, 2021 | -162.15% |
| Sep 30, 2021 | 203.06% |
| Jun 30, 2021 | -202.26% |
| Mar 31, 2021 | 155.60% |
| Dec 31, 2020 | -210.86% |
| Sep 30, 2020 | -121.62% |
| Jun 30, 2020 | 3,580.38% |
| Mar 31, 2020 | 264.11% |
| Dec 31, 2019 | 72.90% |
| Sep 30, 2019 | -279.30% |
| Jun 30, 2019 | 117.56% |
| Mar 31, 2019 | 36.32% |
| Dec 31, 2018 | -179.13% |
| Sep 30, 2018 | 132.05% |
| Jun 30, 2018 | 173.74% |
| Mar 31, 2018 | -9,576.98% |
| Dec 31, 2017 | -95.90% |
| Sep 30, 2017 | -79.20% |
| Jun 30, 2017 | 5,378.82% |
| Mar 31, 2017 | -94.90% |
| Dec 31, 2016 | 547.53% |
| Sep 30, 2016 | 217.85% |
| Jun 30, 2016 | 84.43% |
| Mar 31, 2016 | 86.14% |
| Dec 31, 2015 | -899.85% |
| Sep 30, 2015 | 69.73% |
| Jun 30, 2015 | -92.58% |
| Mar 31, 2015 | 1,431.56% |
| Dec 31, 2014 | 45.37% |
| Sep 30, 2014 | -138.74% |
| Jun 30, 2014 | 1,671.99% |
| Mar 31, 2014 | 68.95% |